McKessonCorporation (MCK) is well-poised for growth, backed by strategic collaborations and strength in the Distribution Solutions segment. However, the company’s opioid-related litigation expenses are a potential threat. Shares of this Zacks Rank #3 (Hold) company have risen 27.7% year to date compared with the industry’s 1.7% growth. The S&P 500 Index has jumped 12.4% in the same time frame. McKesson is a healthcare services and information technology company with a market capitalization of $76.29 billion ...